PCSK9 INHIBITOR

Clinical trials for PCSK9 INHIBITOR explained in plain language.

Never miss a new study

Get alerted when new PCSK9 INHIBITOR trials appear

Sign up with your email to follow new studies for PCSK9 INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Two-Drug combo aims to wipe out rectal cancer before surgery

Disease control Not yet recruiting

This trial investigates whether adding two targeted drugs—tafolecimab and sintilimab—to standard chemoradiation can improve outcomes for people with locally advanced rectal cancer that has not spread. Participants receive short-course radiation followed by chemotherapy plus immun…

Matched conditions: PCSK9 INHIBITOR

Phase: PHASE3 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

PCSK9 INHIBITOR

Get alerted when new PCSK9 INHIBITOR trials appear

Two-Drug combo aims to wipe out rectal cancer before surgery